This document discusses various measures used to quantify disease frequency in epidemiology. It describes measures of morbidity including incidence, prevalence, and disability rates. Incidence measures new cases over time while prevalence measures total current cases. Disability rates quantify limitations in activities. Measures of mortality are also presented, such as crude death rate, case fatality rate, and standardized mortality ratio. Standardization adjusts for differences in population characteristics to allow valid comparisons. Overall, the document provides an overview of key epidemiological metrics for quantifying disease burden and guiding public health efforts.
Measurements of morbidity and mortality
At the end of the session, the students shall be able to
List the basic measurements in epidemiology
Select an appropriate tools of measurement
Measure morbidity & mortality
Perform standardization of rates
Measurements of morbidity and mortality
At the end of the session, the students shall be able to
List the basic measurements in epidemiology
Select an appropriate tools of measurement
Measure morbidity & mortality
Perform standardization of rates
The STUDY of the DISTRIBUTION and DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems."
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
Study design, Epidemiological study designA study design is a specific plan or protocol
for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.
Data
Information
Intelligence
Health information system
Sources of data
Census
Registration of vital events
Sample registration system
Notification of diseases
Hospital records
Disease registers
Record linkage
Epidemiological surveillance
Other health service records
Environmental health data
Health manpower statistics
Population surveys
Other routine statics related to health
Non – quantifiable information
Health management information system
Central Bureau of health Ingelligence
National health profile
WHO Reports
Global Health Observatory
World bank
Health stats
Measurement of Epidemiology
Radha Maharjan
MN (WHD)
Contents
5.1 Morbidity
Incidence
Prevalence
Attack Rate
Contents
5.2 Mortality
Crude Death Rate
Case Fatality Rate
Proportional Mortality Rate
Survival Rate
Standardized Death Rate
Contents
5.3 Disability
Disability Adjusted Life Years (DALY)
Quality Adjusted Life Years (QALY)
5.4 Tools of Measurements
Rate
Ratio
Proportion
5.4 Tools of Measurements
Numerator
Numerator refer to the number of times an event (e.g. number of birth) has occurred in a population, during a specified time period.
Denominator
Numerator has little meaning unless it is related to the denominator. The epidemiologist has to choose an appropriate denominator while calculating a rate.
It may be related to:
(I) population
(II) the total events.
Denominator related to the population
Mid year population
Population at risk
Person – time
Sub groups of the population
Denominator related to the Total Events
Mid year population
The population size changes daily due to births, deaths and migration, the mid year population is commonly chosen as a denominator.
The population as on 1st July is mid-year population.
Population at risk
It is important to note that the calculation of measures of disease frequency depends on correct estimates of the numbers of people under consideration.
Ideally, these figures should include only those people who are potentially susceptible to the disease studied.
Population at risk
For instance, men should not be included in denominator for the carcinoma of cervix.
Part of population, which is susceptible to a disease is called the population at risk,
e.g., Occupational injuries occur only among working people so the population at risk is the workforce.
Person – time
In some epidemiological studies (e.g. cohort studies), person may enter into the study at different times.
Consequently, they are under observation for varying time period.
In such case, the denominator is a combination of person and time.
Person – time
The most frequently used person time is person- years.
Some times this may be person- months, person -weeks or man- hours.
For example, if 10 persons were observed in the study for 10 years, person time would be 100 person years of observation.
Person – time
The same figure would be derived if 100 persons were under observation for one year.
These denominators have the advantage of summarizing the experience of persons with different duration of observation or exposure.
Sub groups of the population
The denominator may be subgroups of population
e.g. under-five, female, doctors, etc.
Denominator related to the Total Events
In some instances, the denominator may be related to total events instead of the total population, as in the case of infant mortality rate the denominator is total number of live births.
Definition concept and comparison of ratio, proportion and rate.
The STUDY of the DISTRIBUTION and DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems."
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
Study design, Epidemiological study designA study design is a specific plan or protocol
for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.
Data
Information
Intelligence
Health information system
Sources of data
Census
Registration of vital events
Sample registration system
Notification of diseases
Hospital records
Disease registers
Record linkage
Epidemiological surveillance
Other health service records
Environmental health data
Health manpower statistics
Population surveys
Other routine statics related to health
Non – quantifiable information
Health management information system
Central Bureau of health Ingelligence
National health profile
WHO Reports
Global Health Observatory
World bank
Health stats
Measurement of Epidemiology
Radha Maharjan
MN (WHD)
Contents
5.1 Morbidity
Incidence
Prevalence
Attack Rate
Contents
5.2 Mortality
Crude Death Rate
Case Fatality Rate
Proportional Mortality Rate
Survival Rate
Standardized Death Rate
Contents
5.3 Disability
Disability Adjusted Life Years (DALY)
Quality Adjusted Life Years (QALY)
5.4 Tools of Measurements
Rate
Ratio
Proportion
5.4 Tools of Measurements
Numerator
Numerator refer to the number of times an event (e.g. number of birth) has occurred in a population, during a specified time period.
Denominator
Numerator has little meaning unless it is related to the denominator. The epidemiologist has to choose an appropriate denominator while calculating a rate.
It may be related to:
(I) population
(II) the total events.
Denominator related to the population
Mid year population
Population at risk
Person – time
Sub groups of the population
Denominator related to the Total Events
Mid year population
The population size changes daily due to births, deaths and migration, the mid year population is commonly chosen as a denominator.
The population as on 1st July is mid-year population.
Population at risk
It is important to note that the calculation of measures of disease frequency depends on correct estimates of the numbers of people under consideration.
Ideally, these figures should include only those people who are potentially susceptible to the disease studied.
Population at risk
For instance, men should not be included in denominator for the carcinoma of cervix.
Part of population, which is susceptible to a disease is called the population at risk,
e.g., Occupational injuries occur only among working people so the population at risk is the workforce.
Person – time
In some epidemiological studies (e.g. cohort studies), person may enter into the study at different times.
Consequently, they are under observation for varying time period.
In such case, the denominator is a combination of person and time.
Person – time
The most frequently used person time is person- years.
Some times this may be person- months, person -weeks or man- hours.
For example, if 10 persons were observed in the study for 10 years, person time would be 100 person years of observation.
Person – time
The same figure would be derived if 100 persons were under observation for one year.
These denominators have the advantage of summarizing the experience of persons with different duration of observation or exposure.
Sub groups of the population
The denominator may be subgroups of population
e.g. under-five, female, doctors, etc.
Denominator related to the Total Events
In some instances, the denominator may be related to total events instead of the total population, as in the case of infant mortality rate the denominator is total number of live births.
Definition concept and comparison of ratio, proportion and rate.
Frequency measures of health is an important aspect in the planing of the type of services required in a specific population. This is due to the fact that they are able to indicate the type and level of health problems being faced In that population during a specified period of time.
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam AggarwalDr. Sonam Aggarwal
Epidemiology is the basic science of Preventive and Social Medicine.
Epidemiology is scientific discipline of public health to study diseases in the community to acquire knowledge for health care of the society. (prevention, control and treatment).
View the webinar on NEET PG counselling - https://www.youtube.com/watch?v=ndtirntqMOM&t=8s
This ppt enumerates all key points to be considered in NEET PG counselling procedure.
View the webinar on NEET PG counselling - https://www.youtube.com/watch?v=ndtirntqMOM&t=8s
Guidance for choosing branch and college post MBBS for PG - MD/MS
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
Video presentation - https://www.youtube.com/watch?v=45CjKnJaIC0
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
Video presentation - https://www.youtube.com/watch?v=45CjKnJaIC0
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
Video of 30 career options after MBBS - https://www.youtube.com/watch?v=Zjkx7yHwa0I
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
Youtube video of this presentation - https://www.youtube.com/watch?v=aIOPf72M3aI&t=8s
Learn Community Medicine along with me : https://t.me/drvkspm
Be my friend by connecting with me through:
Instagram : https://www.instagram.com/drvenkateshkarthikeyan/
Facebook : https://www.facebook.com/drvenkateshkarthikeyan/
Twitter : https://twitter.com/dr_venkatesh_k
Website : www.drvenkateshkarthikeyan.com
LinkedIn : https://in.linkedin.com/in/dr-venkatesh-karthikeyan-8b1234ab
Learn Community Medicine along with me : https://t.me/drvkspm
This ppt discusses about
What is Community based participatory research?
Principles of Community based participatory research
Advantages of Community based participatory research
What is Focus Group Discussion?
Why Focus Group Discussion?
Steps in Focus Group Discussion
Advantages and limitations of Focus Group Discussion
Conclusion
This powerpoint covers the following subtopics:
What is obesity?
Pathogenesis
Burden
Epidemiology of obesity
Assessment of obesity
Consequences of obesity
Prevention and Control
This powerpoint presentations briefs about:
Financial ratios
Categories of Financial ratios
Generating stock ideas
The Due diligence – Checklist
Equity Research
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
1. Measures of
Disease Frequency
Moderators:
Dr Alok Ranjan,
Assistant Professor.
Dr Purushottam Kumar,
Senior Resident
Presenter:
Dr Venkatesh Karthikeyan
JR – 1,Department of CFM
AIIMS Patna
2. •Basics measurements in epidemiology
•Basics requirements of measurements
•Tools of measurements
•Measures of morbidity
•Measures of disability
•Measures of mortality
Contents
3. Epidemiology
• The study of the occurrence and distribution
– of health related events, states and
processes – in specified populations, including
the study of determinants influencing such
processes – and application of this knowledge
to control relevant health problems.
4. Basic measurements in epidemiology
• Epidemiology – key focus is to measure the
morbidity and mortality
• What is required for it?
– Definition of what is to be measured
– Establishment of criteria or standards by which it
can be measured
5. Measurements in Epidemiology
• Measurement of morbidity
• Measurement of disability
• Measurement of mortality
• Measurement of natality
• Measurement of demographic variables
7. Variate vs Circumstance
• Variate – Any piece of information referring to
the patient or his disease.
– Discrete (Cancer lung +/-)
– Continuous (Blood pressure)
• Circumstance – Any factor in the environment
that might be suspected of causing a disease
• E.g: Air pollution
9. Measures of morbidity
Morbidity
- Any departure, subjective or objective,
from a state of physiological well being.
Morbidity can be measured in terms of 3 units
*Persons who were ill
*Illness that the person experienced
*Duration of the illness
10. Measures of morbidity
• Commonly measured aspects of morbidity
– Frequency (measured by incidence and
prevalence)
– Duration
– Severity
11. Measures of morbidity
Why should we measure it?
• Describe the extent and nature of disease
load in community – assist in establishing
priorities
• Provides data essential for research
• Serve as a starting point for etiological
studies, thus playing a crucial role in disease
prevention
• Monitoring and evaluation of disease control
activities
12. Measures of morbidity
iNcidence
• Number of New cases occurring in a defined
population during a specified period of time
• Incidence = (Number of new cases of specific
disease during a given time period/population
at risk during that period) x 1000
13. Measures of morbidity
Incidence
• Example:
– If 500 new cases in a population of 30,000 in a
year is present, then
• Incidence = (500/30000) * 1000
• = 16.7 per 1000 per year
• Incidence rate must include the unit of time
used in the final expression
14. Measures of morbidity
Incidence – Key features
• Refers only to new cases
• During a give time period
• In a specified population or population at risk
(unless other denominators are chosen)
• Uninfluenced by the duration of the disease
• Usually restricted for describing acute conditions
• It can also refer to new spells or episodes of
disease arising in a given period of time per 1000
population
15. Measures of morbidity
Incidence – Key features
• Same person having two spells of flu in a year
= contributes to two spells of sickness in that
year.
• Here, incidence rate is
(Number of spells of sickness starting in a
defined period/mean number of persons
exposed to risk in that period) x 1000
16. Measures of morbidity
Incidence – Special incidence rate
• Attack rate
– Used only when the population is exposed to risk
for a limited period of time, such as during an
epidemic
– It relates the number of cases in the population at
risk and reflects the extent of epidemic
= (Number of new cases of a specified disease
during a specified time interval/ Total population
at risk during the same interval) x 100
17. Measures of morbidity
Incidence – Special incidence rate
Secondary attack rate
- Number of exposed persons developing the
disease within the range of incubation period
following exposure to the primary case.
SAR = (Number of exposed persons developing
the disease within the range of the incubation
period/Total number of exposed contacts) *
100
18. Measures of morbidity
Incidence – Secondary attack rate
• The primary case is excluded from both the
numerator and denominator
• SAR helps us to determine whether a disease
of unknown etiology is communicable or not
• SAR helps to evaluate the effectiveness of
control measures such as isolation and
immunization
19. Measures of morbidity
Incidence rate - Uses
• Useful for taking action to control disease
• For research into etiology and pathogenesis,
distribution of diseases, and efficacy of
preventive and therapeutic measures
• Provides useful insights into the effectiveness
of the health services provided.
20. Measures of morbidity
Prevalence
• Refers specifically to all current cases (old +
new) existing at a given point in time, or over
a period of time in a given population.
• It is the total number of all individuals who
have a disease at a particular time (or period)
divided by the population at risk of having the
disease at this point in time or midway
through the period.
21. Measures of morbidity
Prevalence – Point prevalence
• Number of all current cases at one point of
time, in relation to a defined population.
• Point prevalence
= (Number of all current cases of a specified disease
existing at a given point of time/estimated
population at the same point in time) x 100
• In general, “Prevalence rate” denotes point
prevalence.
22. Measures of morbidity
Prevalence – Period prevalence
• It measures the frequency of all current cases
existing during a defined period of time
expressed in relation to defined population.
• Period prevalence
= (Number of existing cases of a specified disease
during a given period of time interval/Estimated
mid interval population at risk) *100
• It includes cases arising before but extending
into or through to the year as well as those cases
arising during the year
24. Measures of morbidity
Uses of Prevalence
• Helps to estimate the magnitude of the
disease problem in the community
• Useful for administrative and planning
purposes
25. Measures of morbidity
Relationship between prevalence and Incidence
• Prevalence = Incidence x Duration
• Eg;
Incidence = 10 cases/1000 population/year
Mean duration of disease = 5 years
Prevalence = 10 x 5 = 50 per 1000 population
• Similarly,
Incidence = Prevalence / Duration
Duration = Prevalence / Incidence
27. Measures of morbidity
Incidence and Prevalence
• Duration reflects the prognostic factors
• Incidence reflects the causal factors
28. Quality of Life
• Most diseases have a major impact on the afflicted
individuals above and beyond mortality – may not
be lethal, but may be associated with considerable
physical and emotional suffering resulting from the
associated disability.
• Example : Arthritis
• Hence measuring quality of life and developing
valid indices that are useful for obtaining
comparative data in different patients and different
population is essential
29. Disability rates
• In recent years, disability rates related to
illness have come into use to supplement
mortality and morbidity indicators.
• They are based on the notion that health
implies full range of daily activities.
30. Disability rates
• Event type indicators
– Number of days of restricted activity
– Bed disability days
– Work-loss days within a specific period
• Person type indicators
– Limitation of mobility (e.g. Bedridden)
– Limitation of activity (daily activity/major activity)
31. Health Adjusted Life Expectancy
(HALE)
• It is an indicator used to measure healthy life
expectancy
• Earlier it was called Disability – Adjusted life
expectancy (DALE)
• HALE is based on life expectancy at birth, but
includes adjustment for time spent in poor
health.
• It is the equivalent number of years in full health
that a newborn can expect to live based on
current rates of ill-health and mortality.
32. Quality – Adjusted life years
• QALY is a measure of disease burden
(including quality and quantity of life lived)
• Used in assessing the value for money of a
medical intervention
• It is based on the number of years of life that
would be added by intervention.
33. QALY (Contd.)
• Each year in perfect health is assigned a value
of 1.0 down to a value of 0.0 for death, i.e.
• 1 QALY (1 year of life x 1 utility value = 1
QALY) is a year of life lived in perfect health.
• Half a year lived in perfect health is equivalent
to 0.5 QALY (1 year x 0.5 utility value)
34. Disability free life expectancy (DFLE)
• DFLE is synonymous to active life expectancy
• It is the average number of years an individual
is expected to live free of disability – if
current pattern of mortality and disability
continue to apply
35. Disability – adjusted life years
• DALY is a measure of overall disease burden
• Expressed as number of years lost due to ill –
health, disability or early death
• DALY = Years of lost life + Years lost to disability
• 1 DALY = One year of healthy life lost
36. DALY
• Years of lost life is calculated from the number
of deaths at each age multiplied by the
expected remaining years of life according to
a global standard life expectancy.
• Years lost to disability – Number of incident
cases due to injury and illness is multiplied by
the average duration of the disease and a
weighting factor reflecting the severity of the
disease.
37.
38. Measurement of mortality
• Crude death rate
• Specific death rate
• Case fatality rate
• Proportional mortality rate
• Survival rate
• Adjusted or standardized rates
39. Measures of mortality
• Mortality data provide starting point for many
epidemiological studies
• Relatively easy to obtain
• Reasonably accurate in many countries
• Major resource for epidemiologist
40. Limitations of mortality data
• Incomplete reporting of deaths
• Lack of accuracy
– Age
– Cause of death (due to lack of diagnostic
evidence, inexperience of doctor, absence of post
mortem)
• Lack of uniformity
• Choosing single Cause of Death
• Changing coding systems
41. Why do we need mortality data
• For explaining trends and differentials in
overall mortality
• Indicating priorities for health action
• Allocation of resources
• Designing intervention programs
• Assessment and monitoring of public health
problems and programs
• Important clue for epidemiological research
42. Measurement of mortality
Crude Death rate
• (Number of deaths from all causes during the
year/Mid year population) x 1000
• Why it is important?
– Shows the composition of population
– Shows the age specific death rates (reflects the
probability of dying)
43. Measurement of mortality
Crude Death rate
• Disadvantage
– Lack comparability for communities with
populations that differ by age, sex, race, etc.
❑However, CDR should always be examined first
and later the age specific death rate should be
measured – CDR has the ability to portray an
impression in single figure.
44. Measures of mortality
Specific death rates
• Why it is needed?
– Helps us to identify at-risk groups : for preventive
action
– Permit comparison between different causes
within the same population
45. Measures of mortality
Specific death rates
• Cause or disease specific
– E.g: (Number of deaths from tuberculosis during a
calendar year/Mid year population) x 1000
• Related to specific groups
– E.g: (Number of deaths among males during a
calendar year/Mid year population of males) x
1000
46. Measures of mortality
Case fatality Rate
CFR = (Total number of deaths due to a
particular disease/Total number of cases due
to the same disease) x 100
• Denotes the Killing power of the disease
47. Measures of mortality
Case fatality Rate
• It is a proportion
• Typically used in acute infectious diseases like
cholera
• Usefulness in chronic disease is limited
(period from onset to death is long and
variable)
48. Measures of mortality
Proportional mortality rate
PMR = (Number of deaths from the specific
disease in a year/Total deaths from all causes
in that year) x 100
Under 5 PMR = (Number of deaths under 5
years of age in the given year/Total number
of deaths during the same period) x 100
49. Measures of mortality
Proportional mortality rate
• Does not indicate the risk of members of the
population contracting/dying from the
disease.
• Used when population data is not available
• Limited value in making comparisons between
population groups or different time periods
50. Measures of mortality
Survival rate
• Proportion of survivors in a group studied and
followed over a period
• Survival rate = (Total number of patients alive
after 5 years/Total number of patients
diagnosed or treated) x 100
51. Measures of mortality
Survival rate
• It is a method of describing prognosis
• Can be used as a yardstick for assessment of
standards of therapy
• Specially used in cancer studies
52. Measures of mortality
Adjusted or standardized rates
• Standardization removes the confounding
effect of different age structures
• Yields a single standardized or adjusted rate
• by which the mortality experience can be
compared directly
• Adjustment can be made not only for age, but
also sex, race, parity, etc.
53. Measures of mortality - Standardized rates
Direct standardization
(446/53500) x 1000
(60/4000)x1000
54. Measures of mortality - Standardized rates
Direct standardization
• First step – Choose a Standard population
• It is one for which the numbers in each age
and sex group are known
• It can be created by combining two
populations
55. Measures of mortality - Standardized rates
Direct standardization
• Second step – Apply to the standard population, the age
specific rates of the population whose crude death rate is to
be adjusted or standardized 🡪
• As a result, for each age group, an “expected” number of
deaths in the standard population is obtained 🡪
• These are added together from all age groups to give the total
expected deaths
• The final operation is to divide the “expected” total number
of deaths by the total of the standard population, which
yields the standardized or age – adjusted rate.
57. Measures of mortality - Standardized rates
Direct standardization
• “Standardizing” for age distribution has
reduced the crude death rate from 8.3 to 6.56
• Standardized rates have been calculated so
that they can be compared between
themselves – they have no intrinsic meaning
other than this purpose.
58. Measures of mortality - Standardized rates
Indirect age standardization
• Standardized Mortality Ratio
• Life table
• Regression techniques
• Multivariate analysis
59. Measures of mortality - Standardized rates - Indirect age standardization
Standardized Mortality Ratio
• It is a ratio of the total number of deaths that
occur in the study group - to the number of
deaths that would have been expected to
occur - if that study group had experienced
the death rates of a standard population.
• SMR = (Observed deaths/Expected deaths) x 100
60. Measures of mortality - Standardized rates - Indirect age standardization
Standardized Mortality Ratio
• It gives a measure of the likely excess risk of
mortality due to occupation
• If SMR is >100, then the particular occupation
would appear to carry greater mortality risk
than that of the whole population – and the
vice versa
61. Measures of mortality - Standardized rates - Indirect age standardization
Standardized Mortality Ratio
62. Measures of mortality - Standardized rates - Indirect age standardization
Why SMR?
• SMR has the advantage over the direct
method of age adjustment in that it permits
adjustment for age and other factors, where
age specific rates are not available or
unstable because of small numbers.
• It is possible to use SMR if the event of
interest is occurrence of disease , rather than
death.
64. Summary
• Basics measurements in epidemiology
• Basics requirements of measurements
• Tools of measurements
• Measures of morbidity
• Measures of disability
• Measures of mortality
References:
• Park’s textbook of Preventive and Social Medicine – 26th
edition
• Gordis Epidemiology – Sixth edition